References
- Ferguson N , Laydon D , Nedjati Gilani G , et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand; 2020.
- Lauer SA , Grantz KH , Bi Q , et al. The Incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–582.
- Liu Y , Yan L-M , Wan L , et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020. DOI:10.1016/S1473-3099(20)30232-2.
- Coronavirus (COVID-19): World Heath Organization . 2020 [cited 2020 Jul 05]. Available from: https://who.sprinklr.com/.
- Kelly H , Cowling BJ. Case fatality: rate, ratio, or risk? Epidemiology. 2013;24(4):622–2.
- Battegay M , Kuehl R , Tschudin-Sutter S , et al. 2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate–a word of caution. Swiss Med Wkly. 2020;150:0506.
- Lipsitch M , Donnelly CA , Fraser C , et al. Potential biases in estimating absolute and relative case-fatality risks during outbreaks. PLoS Negl Trop Dis. 2015;9(7):e0003846.
- Onder G , Rezza G , Brusaferro S . Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama. 2020. DOI:10.1001/jama.2020.4683